BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report Ruchika Sharma1 May 2023 2:15 PM ISTBengaluru: Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay...
Pfizer, BioNTech dragged to Court over COVID vaccine patent infringement once again Ruchika Sharma6 April 2023 1:30 PM ISTUS: Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming...
BioNTech plans to spend about USD 1 billion more on research this year Ruchika Sharma30 March 2023 10:00 AM ISTThe company said it expects to authorise new share buybacks worth up to $500 million this year, having already spent $1.3 billion on own shares...
BioNTech, OncoC4 collaborate to co-develop and commercialize novel checkpoint antibody in multiple solid tumor indications Ruchika Sharma21 March 2023 2:15 PM ISTUnder the terms of the agreement, OncoC4 will receive a $200 million upfront payment and is eligible to receive development, regulatory and commercial...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
Clinical trials for BioNTech cancer vaccines should start this year in Britain: Ugur Sahin Ruchika Sharma21 Feb 2023 1:30 PM IST"We believe that this should be possible for large amounts of patients before 2030," Sahin said.
BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong Kong Ruchika Sharma27 Dec 2022 1:30 PM ISTShanghai: BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that the Fosun Industrial Co., Limited (as a...
BioNTech begins clinical trial of mRNA-based malaria vaccine candidate Ruchika Sharma25 Dec 2022 12:15 PM ISTThe company said it will initially evaluate different antigens of the parasite that causes malaria over the coming months to help select the...
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
